$USRM·4

U.S. Stem Cell, Inc. · Feb 17, 4:30 PM ET

U.S. Stem Cell, Inc. 4

4 · U.S. Stem Cell, Inc. · Filed Feb 17, 2017

Insider Transaction Report

Form 4
Period: 2017-02-06
TOMAS MIKE
DirectorCEO & President
Transactions
  • Award

    Stock Option (right to buy)

    2017-02-06+10,000,00021,841,284 total
    Exercise: $0.00Exp: 2027-02-06Common Stock (10,000,000 underlying)
Holdings
  • Common Stock

    9,793
Footnotes (1)
  • [F1]2,500,000 vest on 02/06/2018, 2,500,000 vest on 02/06/2019, 2,500,000 vest on 02/06/2020, and 2,500,000 vest on 02/06/2021.

Documents

1 file
  • 4
    form4-tomas021617.xmlPrimary

    OWNERSHIP DOCUMENT